Products for Research Use Only
RegisterLogin

Bismuth potassium citrate

CAT: 0804-HY-B0796-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0796-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
57644-54-9
UNSPSC Description
Bismuth potassium citrate (Bismuth tripotassium dicitrate) is an orally active gastric mucosal protector and has antibacterial and anti-inflammatory activity. Bismuth potassium citrate relieves stomach pain, resists H. pylori growth and repairs gastric mucosa. Bismuth potassium citrate combined with Omeprazole (HY-B0113) has a safe and high efficacy against H. pylori infection, which is promising for research of peptic ulcers, gastric cancer and tubulointerstitial nephritis[1][2][3][4][5][6].
Target Antigen
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bismuth-potassium-citrate.html
Purity
98.0
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].[K+].[K+].[K+].[Bi+3]
Molecular Weight
704.47
References & Citations
[1]Luo HY, et al. Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects[J]. Drugs R D. 2024 Mar;24(1):81-87.|[2]JIANG J X. Efficacy of compound bismuth potassium citrate capsules combined with omeprazole in eradication of Helicobacter pylori infection: A clinical study[J]. Academic Journal of Second Military Medical University, 2010: 973-977.|[3]Mikhailova M, et al. BISMUT-INDUCED ONSET OF ACUTE TUBULOINTERSTICIAL NEPHRITIS: A CLINICAL CASE[J].|[4]Naidenko E S, et al. Obtaining bismuth-potassium citrate[J]. Chemistry for Sustainable Development, 2012, 20: 523-528.|[5]Xuan Y, et al. High-security multifunctional nano-bismuth-sphere-cluster prepared from oral gastric drug for ct/pa dual-mode imaging and chemo-photothermal combined therapy in vivo[J]. Advanced Functional Materials, 2019, 29(18): 1900017.|[6]S M Hinsull, et al. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat. Gut. 1991 Apr;32(4):355-60. doi: 10.1136/gut.32.4.355.J Virol. 2023 Jun 22;e0051223.|Adv Sci (Weinh). 2024 Oct 30:e2408707.|Carbohydr Polym. 2024 Dec 15:346:122645.|Exp Cell Res. 2020 Aug 1;393(1):112054.|Heliyon. 2024 Jan 17.|J Ethnopharmacol. 2024 Jan 12:117759.|J Mol Med (Berl). 2019 Aug;97(8):1183-1193.|J Nanobiotechnology. 2023 Oct 19;21(1):383.|Nat Commun. 2024 Sep 10;15(1):7923.|Nature. 2023 Jun;618(7964):374-382.|Phytother Res. 2024 Mar 25.|SSRN. 2024 Mar 20.|Theranostics. 2020 Jul 25;10(21):9477-9494. |Bioengineered. 2021 Dec;12(2):11610-11621.|Biol Trace Elem Res. 2023 May 8.|Biomed Pharmacother. 2023 Aug 18;166:115333.|Drug Des Devel Ther. 2024 Feb 1:18:259-275.|Front Immunol. 2024 Oct 1:15:1397727.|Front Mol Biosci. 22 July 2022.|Int J Biol Sci. 2024 Aug 6;20(11):4222-4237.|Oxid Med Cell Longev. 2022 Apr 25;2022:3846217.|Research Square Preprint. 2021 Jul.|Food Chem. 2022: 134807.|Nature. 2024 Dec 18.|New J Chem. 03 Aug 2022.|Insect Biochem Mol Biol. 2023 May 12;103958.|Regen Biomater. 2024 Aug 22:11:rbae098.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Clinical Information
Launched

Chemical Information

Bismuth Subcitrate

Bismuth Subcitrate is a mineral compound that is used to treat duodenal and gastric ulcers associated with Helicobacter pylori.

CAS Number57644-54-9
PubChem CID10101269
IUPAC Namebismuth;tripotassium;bis(2-hydroxypropane-1,2,3-tricarboxylate)
Molecular FormulaC12H10BiK3O14
Molecular Weight704.47
Topological Polar Surface Area281
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count14
Rotatable Bond Count4
Heavy Atom Count30
Formal Charge0
Complexity211
SMILES
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+].[Bi+3]
InChI
InChI=1S/2C6H8O7.Bi.3K/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;/q;;+3;3*+1/p-6
InChIKey
ZQUAVILLCXTKTF-UHFFFAOYSA-H
Chemical Structure
2D Structure
2D structure of Bismuth Subcitrate
CAS: 57644-54-9
CID: 10101269
Formula: C12H10BiK3O14
MW: 704.47
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight704.47
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count14
Rotatable Bond Count4
Exact Mass703.87857
Monoisotopic Mass703.87857
Topological Polar Surface Area281 Ų
Heavy Atom Count30
Formal Charge0
Complexity211
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count6
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-B0693ARanitidine (bismuth citrate)
HY-W134002Ammonium bismuth citrate, 99%
HY-16102-01Bismuth subcitrate (potassium)
HY-W133912-01Bismuth (potassium iodide)
HY-16102RBismuth subcitrate (potassium) (Standard)
HY-W111687Bismuth(Ⅲ) citrate, 99.99% trace metals basis
HY-B0550-01Bismuth Subsalicylate
HY-B2181Bismuth subnitrate
HY-B2182Bismuth subcarbonate
HY-B1560Bismuth subgallate

Alternative Products

CatalogName
OR1030087Bismuth Potassium Citrate
CS-O-64029Bismuth Potassium Citrate-d8 (Bismuth Subcitrate-d8)
TRC-B497270-25GBismuth Citrate
GBA88641-01AMMONIUM BISMUTH CITRATE (bismuth ammonium citrate)
T88726-01Ammonium bismuth citrate
40200095-2Bismuth Ammonium Citrate
GX8399-500gBismuth (III) citrate
T71059-01Ranitidine bismuth citrate
FB175286-01Bismuth citrate - USP

Popular Products